-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Zevra Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2013 to 2023.
- Zevra Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $735K, a 304% increase year-over-year.
- Zevra Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $2.05M, a 301% increase year-over-year.
- Zevra Therapeutics, Inc. annual Interest Expense for 2023 was $1.5M, a 348% increase from 2022.
- Zevra Therapeutics, Inc. annual Interest Expense for 2022 was $335K, a 48.2% increase from 2021.
- Zevra Therapeutics, Inc. annual Interest Expense for 2021 was $226K, a 95.3% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)